# Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis

> **NCT01089608** · PHASE2 · COMPLETED · sponsor: **Laboratoires Thea** · enrollment: 93 (actual)

## Conditions studied

- Blepharitis

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Povidone

## Key facts

- **NCT ID:** NCT01089608
- **Lead sponsor:** Laboratoires Thea
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2014-11-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01089608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01089608, "Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01089608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*